Overview

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of high-dose combination chemotherapy and peripheral stem cell transplantation in treating patients who have advanced or recurrent sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
City of Hope Medical Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cisplatin
Doxorubicin
Ifosfamide
Isophosphamide mustard
Liposomal doxorubicin
Melphalan